Antiandrogens as monotherapy for prostate cancer.

Abstract:

:Castration or antiandrogen monotherapies remain options for prostate cancer treatment as only marginal benefits have been demonstrated with combined androgen blockade, although it may be that certain subgroups of patient may benefit. Of the nonsteroidal antiandrogens, bicalutamide 150 mg was as effective as castration in M0 patients with significant improvement in sexual interest and physical capacity, but the trial has yet to reach maturity. In M1 patients, bicalutamide 150 mg was not as effective as castration but this may be outweighed by symptomatic and quality of life benefits. Nilutamide is not recommended as monotherapy and there are little data on flutamide. The steroidal antiandrogen, cyproterone acetate, is as effective as oestrogen therapy and has a better side-effect profile, although cardiovascular and hepatic side effects are still of concern. Compared with flutamide, in a recently completed EORTC study, side effects such as gynaecomastia, diarrhoea, nausea, and liver function deterioration occurred less often, and thrombotic effects more often, in the cyproterone acetate group. No difference was seen in the preservation of sexual functioning. Quality of life issues are becoming increasingly important and thus antiandrogen monotherapy may become more widely used in the management of prostate cancer.

journal_name

Eur Urol

journal_title

European urology

authors

Schröder FH

doi

10.1159/000052291

subject

Has Abstract

pub_date

1998-01-01 00:00:00

pages

12-7

eissn

0302-2838

issn

1873-7560

journal_volume

34 Suppl 3

pub_type

杂志文章,评审
  • Genomic Characterization of Renal Cell Carcinoma with Sarcomatoid Dedifferentiation Pinpoints Recurrent Genomic Alterations.

    abstract:BACKGROUND:The genomic features underpinning renal cell carcinoma with sarcomatoid dedifferentiation (sRCC) are not well understood, and at present, there are no specific or effective therapies for sRCC. OBJECTIVE:To identify genomic alterations in patients with sRCC. DESIGN, SETTING, AND PARTICIPANTS:We conducted ge...

    journal_title:European urology

    pub_type: 杂志文章

    doi:10.1016/j.eururo.2016.01.051

    authors: Malouf GG,Ali SM,Wang K,Balasubramanian S,Ross JS,Miller VA,Stephens PJ,Khayat D,Pal SK,Su X,Sircar K,Tamboli P,Jonasch E,Tannir NM,Wood CG,Karam JA

    更新日期:2016-08-01 00:00:00

  • Effects of 3 months' neoadjuvant hormonal treatment with a GnRH analogue (triptorelin) prior to radical retropubic prostatectomy on prostate-specific antigen and tumour volume in prostate cancer.

    abstract::In this retrospective study the relationship between serum prostate-specific antigen (PSA) and tumour volume (assessed by the planimetric method on whole mount section) was analysed in 56 patients subjected to radical prostatectomy, of whom 28 received 3 months of neoadjuvant GnRH analogue (triptorelin) treatment. Ser...

    journal_title:European urology

    pub_type: 临床试验,杂志文章

    doi:10.1159/000475337

    authors: Aus G,Brändstedt S,Häggman M,Pedersen K,de la Torre M,Hugosson J

    更新日期:1994-01-01 00:00:00

  • What are the Benefits and Harms of Ureteroscopy Compared with Shock-wave Lithotripsy in the Treatment of Upper Ureteral Stones? A Systematic Review.

    abstract:CONTEXT:Extracorporeal shock wave lithotripsy (SWL) and ureteroscopy (URS), with or without intracorporeal lithotripsy, are the most common treatments for upper ureteric stones. With advances in technology, it is unclear which treatment is most effective and/or safest. OBJECTIVE:To systematically review literature rep...

    journal_title:European urology

    pub_type: 杂志文章,评审

    doi:10.1016/j.eururo.2017.04.016

    authors: Drake T,Grivas N,Dabestani S,Knoll T,Lam T,Maclennan S,Petrik A,Skolarikos A,Straub M,Tuerk C,Yuan CY,Sarica K

    更新日期:2017-11-01 00:00:00

  • Intramuscular diclofenac versus intravenous indomethacin in the treatment of acute renal colic.

    abstract:OBJECTIVE:We have conducted a clinical trial to compare the pain-relieving effect and safety of diclofenac administered intramuscularly to indomethacin given intravenously. METHODS:The study was designed as a randomized single-blind trial. It was carried out at Oslo Emergency Hospital (outpatient setting or stay < 24 ...

    journal_title:European urology

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:10.1159/000474196

    authors: Laerum E,Ommundsen OE,Grønseth JE,Christiansen A,Fagertun HE

    更新日期:1996-01-01 00:00:00

  • The bacteriology of operated renal stones.

    abstract::In a group of patients consecutively operated on for renal stones, more than half of the patients had urinary tract infection. In a significant number of the patients with infection stones containing magnesium ammonium phosphate, no urease-producing microorganism could be cultured. Escherichia coli was on the other ha...

    journal_title:European urology

    pub_type: 杂志文章

    doi:10.1159/000464001

    authors: Bratell S,Brorson JE,Grenabo L,Hedelin H,Pettersson S

    更新日期:1990-01-01 00:00:00

  • Percutaneous pyelolithotomy. Case report and technical comments.

    abstract::A case of nonoperative renal stone extraction through a nephrostomy tract is described. The stone was removed with the aid of a newly constructed device. The advantage of this device over a Dormia stone basket is that it has a steerable tip, which facilitates trapping of the stone in the basket. ...

    journal_title:European urology

    pub_type: 杂志文章

    doi:

    authors: Hellsten S,Frank B,Hildell J

    更新日期:1980-01-01 00:00:00

  • Delay in the surgical treatment of bladder cancer and survival: systematic review of the literature.

    abstract:OBJECTIVES:Eighty per cent of the newly diagnosed invasive bladder tumours are invasive from the outset. Half of these patients already have occult distant metastases reflecting the rapid nature of progression. The aim of the current study was to review the literature to determine if delay in cystectomy leads to worse ...

    journal_title:European urology

    pub_type: 杂志文章,评审

    doi:10.1016/j.eururo.2006.05.046

    authors: Fahmy NM,Mahmud S,Aprikian AG

    更新日期:2006-12-01 00:00:00

  • p53 immunoreactivity as prognostic marker for cancer-specific survival in prostate cancer.

    abstract:OBJECTIVES:The objective of this study was to evaluate the role of p53 immunoreactivity as a prognostic marker in prostate cancer. METHODS:The nuclear accumulation of the aberrant p53 protein was determined by immunohisto-chemistry on surgical specimens and related to stage, grade and cancer-specific survival in 186 p...

    journal_title:European urology

    pub_type: 杂志文章

    doi:10.1159/000474147

    authors: Stattin P,Bergh A,Karlberg L,Nordgren H,Damber JE

    更新日期:1996-01-01 00:00:00

  • Gastrointestinal presentation of germ cell malignancy.

    abstract:OBJECTIVES:To summarize monoinstitutional experience with gastrointestinal (GI) presentations of germ cell malignancy and to review recent medical literature on this issue. METHODS:Retrospective review of 5 cases with advanced germ cell malignancy (testicular 2 and retroperitoneal 3) and involvement of the upper GI tr...

    journal_title:European urology

    pub_type: 杂志文章,评审

    doi:10.1159/000020368

    authors: Nord C,Fosså SD,Giercksky KE

    更新日期:2000-12-01 00:00:00

  • EAU guidelines on pain management.

    abstract::Pain is the most common symptom of any illness; the physician's therapeutic task is twofold: to discover and treat the cause of pain and the pain itself, whether or not the underlying cause is treatable, to provide relief and reduce the suffering caused by pain. Although we use the term of pain to define all sensation...

    journal_title:European urology

    pub_type: 指南,杂志文章,实务指引

    doi:10.1016/s0302-2838(03)00321-x

    authors: Francesca F,Bader P,Echtle D,Giunta F,Williams J,EAU.

    更新日期:2003-10-01 00:00:00

  • Prediction of High-grade Prostate Cancer Following Multiparametric Magnetic Resonance Imaging: Improving the Rotterdam European Randomized Study of Screening for Prostate Cancer Risk Calculators.

    abstract:BACKGROUND:The Rotterdam European Randomized Study of Screening for Prostate Cancer risk calculators (ERSPC-RCs) help to avoid unnecessary transrectal ultrasound-guided systematic biopsies (TRUS-Bx). Multivariable risk stratification could also avoid unnecessary biopsies following multiparametric magnetic resonance ima...

    journal_title:European urology

    pub_type: 杂志文章,多中心研究

    doi:10.1016/j.eururo.2018.07.031

    authors: Alberts AR,Roobol MJ,Verbeek JFM,Schoots IG,Chiu PK,Osses DF,Tijsterman JD,Beerlage HP,Mannaerts CK,Schimmöller L,Albers P,Arsov C

    更新日期:2019-02-01 00:00:00

  • Robotic partial nephrectomy for complex renal tumors: surgical technique.

    abstract:OBJECTIVES:Laparoscopic partial nephrectomy requires advanced training to accomplish tumor resection and renal reconstruction while minimizing warm ischemia times. Complex renal tumors add an additional challenge to a minimally invasive approach to nephron-sparing surgery. We describe our technique, illustrated with vi...

    journal_title:European urology

    pub_type: 杂志文章

    doi:10.1016/j.eururo.2007.09.047

    authors: Rogers CG,Singh A,Blatt AM,Linehan WM,Pinto PA

    更新日期:2008-03-01 00:00:00

  • Comparison of partial nephrectomy and percutaneous ablation for cT1 renal masses.

    abstract:BACKGROUND:Partial nephrectomy (PN) is a preferred treatment for cT1 renal masses, whereas thermal ablation represents an alternative nephron-sparing option, albeit with higher reported rates of recurrence. OBJECTIVE:To review our experience with PN, percutaneous radiofrequency ablation (RFA), and percutaneous cryoabl...

    journal_title:European urology

    pub_type: 杂志文章

    doi:10.1016/j.eururo.2014.07.021

    authors: Thompson RH,Atwell T,Schmit G,Lohse CM,Kurup AN,Weisbrod A,Psutka SP,Stewart SB,Callstrom MR,Cheville JC,Boorjian SA,Leibovich BC

    更新日期:2015-02-01 00:00:00

  • Adjuvant chemotherapy in invasive bladder cancer: a systematic review and meta-analysis of individual patient data Advanced Bladder Cancer (ABC) Meta-analysis Collaboration.

    abstract:OBJECTIVES:To evaluate the effect of adjuvant chemotherapy in invasive bladder cancer. METHODS:: We conducted a systematic review and meta-analysis of updated individual patient data from all available randomised controlled trials comparing local treatment plus adjuvant chemotherapy versus the same local treatment alo...

    journal_title:European urology

    pub_type: 杂志文章,meta分析

    doi:10.1016/j.eururo.2005.04.005

    authors: Advanced Bladder Cancer (ABC) Meta-analysis Collaboration.

    更新日期:2005-08-01 00:00:00

  • Updated Guidelines for Metastatic Hormone-sensitive Prostate Cancer: Abiraterone Acetate Combined with Castration Is Another Standard.

    abstract::Addition of docetaxel to androgen deprivation therapy (ADT) was recommended for patients with newly diagnosed metastatic hormone-sensitive prostate cancer (mHSPC), who are fit enough to receive docetaxel. Two recently published trials showed that the addition of abiraterone acetate plus prednisone to ADT has a clear s...

    journal_title:European urology

    pub_type: 社论

    doi:10.1016/j.eururo.2017.09.029

    authors: Mottet N,De Santis M,Briers E,Bourke L,Gillessen S,Grummet JP,Lam TB,van der Poel HG,Rouvière O,van den Bergh RCN,Cornford P

    更新日期:2018-03-01 00:00:00

  • BTA stat and BTA TRAK: A comparative evaluation of urine testing for the diagnosis of transitional cell carcinoma of the bladder.

    abstract:OBJECTIVE:We compared the BTA (bladder tumor antigen) stat test with the BTA TRAK assay in patients highly suspicious of bladder cancer. METHODS:The BTA stat and the BTA TRAK tests are two immunoassays that detect human complement factor H related protein in urine, employing the same antibody pair. The BTA stat is a q...

    journal_title:European urology

    pub_type: 临床试验,杂志文章

    doi:10.1159/000019824

    authors: Irani J,Desgrandchamps F,Millet C,Toubert ME,Bon D,Aubert J,Le Duc A

    更新日期:1999-02-01 00:00:00

  • Use of computerized cell image analysis to characterize cell nucleus populations from normal and neoplastic renal tissues.

    abstract::We studied 55 renal tissue samples from 16 patients corresponding to normal (19 samples, group 1), low-grade (18 samples, group 2), and high-grade (18 samples, group 3) tumoral tissues. For this purpose, we used digital cell image analysis (the SAMBA 200 processor) to describe the morphonuclear patterns of Feulgen-sta...

    journal_title:European urology

    pub_type: 杂志文章

    doi:10.1159/000473605

    authors: vanden Houte K,Kiss R,de Prez C,Verhest A,Pasteels JL,van Velthoven R

    更新日期:1991-01-01 00:00:00

  • Genomic Predictors of Outcome in Prostate Cancer.

    abstract:CONTEXT:Given the highly variable behavior and clinical course of prostate cancer (PCa) and the multiple available treatment options, a personalized approach to oncologic risk stratification is important. Novel genetic approaches offer additional information to improve clinical decision making. OBJECTIVE:To review the...

    journal_title:European urology

    pub_type: 杂志文章,评审

    doi:10.1016/j.eururo.2015.04.008

    authors: Boström PJ,Bjartell AS,Catto JW,Eggener SE,Lilja H,Loeb S,Schalken J,Schlomm T,Cooperberg MR

    更新日期:2015-12-01 00:00:00

  • Renal cell carcinoma guideline.

    abstract:OBJECTIVES:The European Association of Urology (EAU) Guideline Group for renal cell carcinoma (RCC) prepared this guideline to help urologists assess the evidence-based management of RCC and to incorporate the guideline recommendations into their clinical practice. METHODS:The recommendations provided in the current g...

    journal_title:European urology

    pub_type: 杂志文章,实务指引

    doi:10.1016/j.eururo.2007.03.035

    authors: Ljungberg B,Hanbury DC,Kuczyk MA,Merseburger AS,Mulders PF,Patard JJ,Sinescu IC,European Association of Urology Guideline Group for renal cell carcinoma.

    更新日期:2007-06-01 00:00:00

  • Gleason scores from prostate biopsies obtained with 18-gauge biopsy needles poorly predict Gleason scores of radical prostatectomy specimens.

    abstract:OBJECTIVES:Prostate cancer is the most frequent cancer among men in the US. Histological grading is an important part of the diagnostic evaluation aside from clinical staging and serum PSA. The most commonly used grading system is the one described by Gleason. From a prognostic point of view, it is of considerable inte...

    journal_title:European urology

    pub_type: 杂志文章

    doi:10.1159/000019578

    authors: Djavan B,Kadesky K,Klopukh B,Marberger M,Roehrborn CG

    更新日期:1998-01-01 00:00:00

  • Is Gleason Grade 5 Prostate Cancer Resistant to Conventional Androgen Deprivation Therapy?

    abstract::Synthesis of data from randomized trials suggests that long-term versus short-term androgen deprivation therapy may be most effective in men with Gleason grade 4 prostate cancer (PCa) and less or ineffective in men with Gleason grade 5 PCa. ...

    journal_title:European urology

    pub_type: 社论

    doi:10.1016/j.eururo.2015.08.057

    authors: D'Amico AV

    更新日期:2016-05-01 00:00:00

  • Radical nephrectomy with and without lymph node dissection: preliminary results of the EORTC randomized phase III protocol 30881. EORTC Genitourinary Group.

    abstract:OBJECTIVE:The authors present demographic and surgical data from a randomized phase III trial, instituted by the EORTC Genitourinary Group in 1988, the aim of which was to assess whether complete lymph node dissection in conjunction with radical nephrectomy for renal cell cancer is more effective than radical nephrecto...

    journal_title:European urology

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:10.1159/000020050

    authors: Blom JH,van Poppel H,Marechal JM,Jacqmin D,Sylvester R,Schröder FH,de Prijck L

    更新日期:1999-12-01 00:00:00

  • The relation of lower urinary tract symptoms with life-style factors and objective measures of benign prostatic enlargement and obstruction: an Italian survey.

    abstract:OBJECTIVES:The association between the severity of LUTS and prostate volume, prostate-related variables and general life-style factors was investigated in a large number of patients with persistent LUTS suggestive of BPH (LUTS/BPH). METHODS:Patients with LUTS/BPH aged between 50 and 80 years, were enrolled in this Ita...

    journal_title:European urology

    pub_type: 杂志文章,多中心研究

    doi:10.1016/j.eururo.2004.01.011

    authors: Tubaro A,La Vecchia C,Uroscreening Study Group.

    更新日期:2004-06-01 00:00:00

  • A Systematic Review and Framework for the Use of Hormone Therapy with Salvage Radiation Therapy for Recurrent Prostate Cancer.

    abstract:CONTEXT:Salvage radiotherapy (SRT) is a standard of care for men who recur postprostatectomy, and recent randomized trials have assessed the benefit and toxicity of adding hormone therapy (HT) to SRT with differing results. OBJECTIVE:To perform a systematic review of randomized phase III trials of the use of SRT ± HT ...

    journal_title:European urology

    pub_type: 杂志文章

    doi:10.1016/j.eururo.2017.06.027

    authors: Spratt DE,Dess RT,Zumsteg ZS,Lin DW,Tran PT,Morgan TM,Antonarakis ES,Nguyen PL,Ryan CJ,Sandler HM,Cooperberg MR,Posadas E,Feng FY

    更新日期:2018-02-01 00:00:00

  • Needle tract seeding following puncture of retroperitoneal liposarcoma.

    abstract::9 case of needle tract seeding following percutaneous puncture of an avascular mass, which proved to be a retroperitoneal liposarcoma, is presented. ...

    journal_title:European urology

    pub_type: 杂志文章

    doi:10.1159/000474128

    authors: Hidai H,Sakuramoto T,Miura T,Nakahashi M,Kikyo S

    更新日期:1983-01-01 00:00:00

  • Nephroblastoma associated with mesangioproliferative glomerulonephritis.

    abstract::The case of a girl showing left-sided Wilms tumor together with a nephrotic syndrome is presented. Recovery after tumor nephrectomy was uneventful. After cessation of cytostatic chemotherapy chronic renal failure developed. Open wedge biopsy of the right kidney revealed endstage glomerular disease. Renal histology in ...

    journal_title:European urology

    pub_type: 杂志文章

    doi:10.1159/000473495

    authors: Ringert RH,Pistor K

    更新日期:1982-01-01 00:00:00

  • Quality of life as an outcome measure in cancer clinical trials.

    abstract::In the past decade, increasing attention has been given to more systematic and quantitative ways of evaluating explicitly the impact of diseases and medical interventions on quality of life. A substantial part of this research pertained to the field of cancer where cure is not always possible and treatments are mostly...

    journal_title:European urology

    pub_type: 杂志文章,评审

    doi:10.1159/000474532

    authors: Kiebert GM

    更新日期:1997-01-01 00:00:00

  • A novel robotic system for single-port urologic surgery: first clinical investigation.

    abstract:BACKGROUND:The idea of performing a laparoscopic procedure through a single abdominal incision was conceived with the aim of expediting postoperative recovery. OBJECTIVE:To determine the clinical feasibility and safety of single-port urologic procedures by using a novel robotic surgical system. DESIGN, SETTING, AND P...

    journal_title:European urology

    pub_type: 临床试验,杂志文章

    doi:10.1016/j.eururo.2014.06.039

    authors: Kaouk JH,Haber GP,Autorino R,Crouzet S,Ouzzane A,Flamand V,Villers A

    更新日期:2014-12-01 00:00:00

  • Retinoids in chemoprevention.

    abstract::Over several decades, in vitro experimental studies have demonstrated that retinoids effect the process of carcinogenesis and tend towards the alteration of cells back to more normal differentiation. This hypothesis has formed the basis of several chemopreventive studies in breast cancer, cervical cancer, head and nec...

    journal_title:European urology

    pub_type: 杂志文章,评审

    doi:10.1159/000019874

    authors: Whelan P

    更新日期:1999-01-01 00:00:00

  • Advances and trends in hormonal therapy for advanced prostate cancer.

    abstract::Hormonal therapy represents first-line treatment for patients with advanced prostate cancer. Generally, surgical castration is viewed as the 'gold standard' but carries with it a psychological effect. Medical alternatives include LHRH analogues, antiandrogens, and oestrogens, though the last of these is associated wit...

    journal_title:European urology

    pub_type: 杂志文章,评审

    doi:10.1159/000475049

    authors: Debruyne FM,Dijkman GA

    更新日期:1995-01-01 00:00:00